In a murine model of ovarian cancer, inhibition of Axl promotes tumor infiltration of CD8+ T cell and CD103+ DCs associated with an upregulation of the T cell recruiting chemokines CXCL9 and CXCL10. The gene discussed is CD8A; the disease is ovarian carcinoma.